Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1 28Phase 3 21Phase 1/2 18Phase 4 9Phase NA 3Phase 2/3 2Phase EARLY_PHASE1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 57OTHER_GOV 4INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 272Breast 190Genitourinary 135Thoracic 122Lymphoid 71Gynecologic 57Head & Neck 54Dermatologic 53CNS 46Tumor-Agnostic 36Other hematologic neoplasm 36Sarcoma 30Plasma cell 24Other solid neoplasm 19Other 7Endocrine 6Classical hematology 6Other neoplasm 4NET 3Myeloid 3

Conditions

Neuroendocrine Tumors 3Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Neoplasm Metastasis 1Liver Neoplasms 1Liver Diseases 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Colonic Diseases 1Carcinoma, Neuroendocrine 1Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Surgical Procedures, Operative 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × NET × Clear all
NCT07377487 2026-05-22

INDIGO

Boston Scientific Corporation

Phase NA Recruiting
51 enrolled
EndocrineGastrointestinalNET

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT05017662 2025-09-04

A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

Ariceum Therapeutics GmbH

Phase NA Completed
20 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03012789 2024-04-30

NETest_Sx

Wren Laboratories LLC

Phase NA Active not recruiting
40 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡